Skip to content

Cohort study of Chinese and Western medicine against severe influenza

Cohort study of Chinese and Western medicine against severe influenza

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2100004555
Enrollment
Unknown
Registered
2020-12-23
Start date
2017-01-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

influenza

Interventions

Sponsors

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: According to the influenza diagnosis and treatment plan (2018 Edition) issued by the national health and Family Planning Commission, the patient was diagnosed with influenza, and the condition met one of the following conditions: 1. Continuous high fever (39 degrees C) > 3 days, accompanied by severe cough, purulent sputum, blood sputum, or chest pain; 2. Respiratory tachycardia >= 24 times / min, dyspnea and cyanosis of lips; 3. Change of mind: slow reaction, drowsiness, restlessness, convulsion, etc; 4. Severe vomiting, diarrhea and dehydration; 5. It is complicated with pneumonia; 6. The original underlying diseases were significantly aggravated.

Exclusion criteria

Exclusion criteria: The continuous cases of severe influenza treated with Xiyanping injection and Western medicine alone were treated in each research center during the study period.

Design outcomes

Primary

MeasureTime frame
Length of hospitalization;

Secondary

MeasureTime frame
Incidence of complications;Antipyretic time;28 day mortality;Antibiotic use rate and bacterial infection rate;

Countries

China

Contacts

Public ContactLiu Qingquan

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University

liuqingquan2003@126.com+86 10-52176520

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026